Treatment Results with Transurethral Hyperthermia in Patients with Benign Prostatic Hyperplasia

  • Luc Baert
  • Filip Ameye
  • Zbigniew Petrovich


Surgery is the modality of choice in the treatment of patients with moderate to severe symptoms and signs of benign prostatic hyperplasia (BPH) (Graversonet al. 1989). Patients with these signs and symptoms who are poor surgical risks [American Society of Anesthesiologists (ASA) group ≥ 3] have limited treatment options (New Classification of Physical Status 1963). Transrectal microwave hyperthermia (TRHT) has been in use as a treatment for poor surgical risk BPH patients since 1980. Major improvement was reported in more than 70% of patients, with no treatment complications of importance being seen (Yerushalmi et al. 1985; Lindner et al. 1990). Other investigators, however, could not reproduce these excellent treatment results (Strohmaier et al. 1990; Stawarz et al. 1991). In a report by Strohmaier et al. (1990), no convincing evidence of therapeutic activity was noted in 32 patients treated with TRHT (see Chap. 19).


Benign Prostatic Hyperplasia Median Lobe Average Flow Rate Peak Flow Rate Irritative Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Astrahan MA, Saponzink MD, Cohen D, et al. (1989) Microwave applicator for transurethral hyperthermia of benign prostatic hyperlasia. Int J Hyperthermia 5:283–296PubMedCrossRefGoogle Scholar
  2. Astrahan MA, Ameye F, Oyen R, et al. (1991a) Interstitial temperature measurements during transurethral microwave hyperthermia. J Urol 145:304–308PubMedGoogle Scholar
  3. Astrahan MA, Imanaka K, Jozsef G, et al. (1991b) Heating characteristics of a helical microwave applicator for transurethral hyperthermia of benign prostatic hyperplasia. Int J Hyperthermia 7:141–145PubMedCrossRefGoogle Scholar
  4. Baert L, Ameye F, Willemen P, et al. (1990) Transurethral microwave hyperthermia for benign prostatic hyperplasia: preliminary clinical pathological results. J Urol 144:1383–1387PubMedGoogle Scholar
  5. Baert L, Willemen P, Ameye F, et al. (1991) Transurethral microwave hyperthermia: treatment response in different forms of benign prostatic hyperplasia. Prostate 18:315–320PubMedCrossRefGoogle Scholar
  6. Boyarsky S, Jones G, Paulson DF, et al. (1977) A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg 68:28–32Google Scholar
  7. Graverson PH, Gasser TC, Wasson JH, et al. (1989) Controversies about indications for transurethral resection of the prostate. J Urol 141.475–481Google Scholar
  8. Lauweryns J, Baert L, Vandehove J, et al. (1991) Histopathology of prostatic tissue after transurethral hyperthermia. Int J Hyperthermia 7:221–230PubMedCrossRefGoogle Scholar
  9. Lindner A, Braf Z, Lev A, et al. (1990) Local hyperthermia of the prostatic gland for the treatment of benign prostatic hypertrophy and urinary retention. Br J Urol 65:201–203PubMedCrossRefGoogle Scholar
  10. New Classification of Physical Status (1963) The 1962 House of Delegates of the American Society of Anesthesiologists. Anesthesiol 2: 111Google Scholar
  11. Sapozink MD, Boyd S, Astrahan MA, et al. (1990) Transurethral hyperthermia for benign prostatic hyperplasia with preliminary clinical results. J Urol 143:944–950PubMedGoogle Scholar
  12. Stawarz B, Szmigielski S, Ogrodnik J, et al. (1991) A comparison of transurethral and transrectal microwave hyperthermia in poor surgical risk BPH patients. J Urol 146:353–357PubMedGoogle Scholar
  13. Strohmaier WL, Bichler KH, Fluchter SH, et al. (1990) Local microwave hyperthermia of benign prostatic hyperplasia. J Urol 144:913–917PubMedGoogle Scholar
  14. Yerushalmi A, Fishelovitz Y, Singer D, et al. (1985) Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia, J Urol 133:873–876PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • Luc Baert
    • 1
    • 2
  • Filip Ameye
    • 1
  • Zbigniew Petrovich
    • 3
  1. 1.Department of Urology, St. Pieter’s HospitalCatholic University of LeuvenLeuvenBelgium
  2. 2.University of Southern California, School of MedicineLos AngelesUSA
  3. 3.Department of Radiation Oncology, Kenneth Norris Jr. Cancer CenterUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations